Novartis Adds LABA/LAMA Combination Ultibro to Lineup of Breezhaler Products for COPD Using the Same Inhaler

Novartis Pharma’s Primary Care medical sales reps have begun detailing the chronic obstructive pulmonary disease (COPD) treatment Ultibro (indacaterol + glycopyrronium) together with the company’s two other products in the field of respiratory diseases. Novartis has relatively little experience in...read more